Related references
Note: Only part of the references are listed.Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men
J. -M. Kaufman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Effects of strontium on proliferation and differentiation of rat bone marrow mesenchymal stem cells
Yunfeng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Reduction by strontium of the bone marrow adiposity in mice and repression of the adipogenic commitment of multipotent C3H10T1/2 cells
C. Fournier et al.
BONE (2012)
Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women
J. Y. Reginster et al.
BONE (2012)
Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper
J. Goldhahn et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)
C. Cooper et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
J-Y. Reginster et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis Results of a 2-year study
R. Rizzoli et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Estrogen and the skeleton
Sundeep Khosla et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: Involvement of osteoprotegerin
Songlin Peng et al.
BONE (2011)
Adverse Reactions and Drug-Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
Rene Rizzoli et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate
Audrey Doublier et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Osteoprotegerin Deficiency Attenuates Strontium-Mediated Inhibition of Osteoclastogenesis and Bone Resorption
Songlin Peng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture
V. Geoffroy et al.
OSTEOPOROSIS INTERNATIONAL (2011)
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis
P. J. Marie et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Cutaneous side effects of antiosteoporosis treatments
Philippe Musette et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2011)
Strontium ranelate improves implant osseointegration
Laurent Maimoun et al.
BONE (2010)
Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age
Ego Seeman et al.
BONE (2010)
Effects of Alendronate and Strontium Ranelate on Cancellous and Cortical Bone Mass in Glucocorticoid-Treated Adult Rats
P. Sun et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium Ranelate
Olivia Fromigue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
Pierre J. Marie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Mineralization Density Distribution of Postmenopausal Osteoporotic Bone Is Restored to Normal After Long-Term Alendronate Treatment: qBEI and sSAXS Data From the Fracture Intervention Trial Long-Term Extension (FLEX)
P. Roschger et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study
Roger M. D. Zebaze et al.
LANCET (2010)
Strontium Ranelate Decreases Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclastic Differentiation In Vitro: Involvement of the Calcium-Sensing Receptor
Axelle Caudrillier et al.
MOLECULAR PHARMACOLOGY (2010)
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years
O. Bruyere et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women
M. Hiligsmann et al.
OSTEOPOROSIS INTERNATIONAL (2010)
In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization
G. Boivin et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database
G. Breart et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats
Y. F. Li et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
P. Musette et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures
V. Rabenda et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis
Ren Rizzoli et al.
RHEUMATOLOGY INTERNATIONAL (2010)
Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis
Mickael Hiligsmann et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years
J. Y. Reginster et al.
BONE (2009)
Osteoblasts play key roles in the mechanisms of action of strontium ranelate
T. C. Brennan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
The Calcium-sensing Receptor Is Involved in Strontium Ranelate-induced Osteoclast Apoptosis NEW INSIGHTS INTO THE ASSOCIATED SIGNALING PATHWAYS
Anne S. Hurtel-Lemaire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis
Robert R. Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate
Olivia Fromigué et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response
G. J. Atkins et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants
S. D. Bain et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Influence of remodeling on the mineralization of bone tissue
G. Boivin et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
P. J. Meunier et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis - Results of a five-year, randomized, placebo-controlled trial
Jean-Yves Reginster et al.
ARTHRITIS AND RHEUMATISM (2008)
Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms
Joseph Caverzasio
BONE (2008)
Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro
Edith Bonnelye et al.
BONE (2008)
Intelligent risk communication - Can it be improved?
Andrzej Czarnecki
DRUG SAFETY (2008)
Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis
P. Marquis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia
Ego Seeman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Histomorphometric and μCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate
Monique E. Arlot et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate
O. Bruyere et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength
Patrick Ammann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation
Naibedya Chattopadhyay et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: Involvement of prostaglandins
Shilpa Choudhary et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older
Ego Seeman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors
C Roux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
LG Raisz
JOURNAL OF CLINICAL INVESTIGATION (2005)
Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone
D Farlay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
JY Reginster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells
A Barbara et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
PJ Meunier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats
P Ammann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
S 12911-2 inhibits osteoclastic bone resorption in vitro
N Takahashi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis
E Seeman
OSTEOPOROSIS INTERNATIONAL (2003)
Incorporation and distribution of strontium in bone
SG Dahl et al.
BONE (2001)
Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: The QUALIOST (TM)
P Marquis et al.
QUALITY OF LIFE RESEARCH (2001)
Share Paper
